CHI3L1 and bipolar disorder: In the present study that was conducted to evaluate serum Galectin‐1, Galectin‐9, and YKL‐40 levels in patients with bipolar disorder, compare them with healthy controls, and test the relationship with cognitive functions, serum Galectin‐1 levels were found to be significantly lower in patients with bipolar disorder.